152 related articles for article (PubMed ID: 33101594)
21. 2-Substituted-1-(2-morpholinoethyl)-1H-naphtho[2,3-d]imidazole-4,9-diones: Design, synthesis and antiproliferative activity.
Liu Z; Zhang Z; Zhang W; Yan D
Bioorg Med Chem Lett; 2018 Aug; 28(14):2454-2458. PubMed ID: 29884536
[TBL] [Abstract][Full Text] [Related]
22. QSAR on antiproliferative naphthoquinones based on a conformation-independent approach.
Duchowicz PR; Bennardi DO; Bacelo DE; Bonifazi EL; Rios-Luci C; Padrón JM; Burton G; Misico RI
Eur J Med Chem; 2014 Apr; 77():176-84. PubMed ID: 24631897
[TBL] [Abstract][Full Text] [Related]
23. Identification of ortho-naphthoquinones as anti-AML agents by highly efficient oxidation of phenols.
Huang H; Yan M; Chen J; Yuan B; Chen G; Cheng S; Huang D; Gao Z; Cao C
Bioorg Chem; 2019 May; 86():97-102. PubMed ID: 30685647
[TBL] [Abstract][Full Text] [Related]
24. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
Shahsavari Z; Karami-Tehrani F; Salami S
Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Evaluation of New Naphthalene and Naphthoquinone Derivatives as Anticancer Agents.
Beretta GL; Ribaudo G; Menegazzo I; Supino R; Capranico G; Zunino F; Zagotto G
Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27990691
[TBL] [Abstract][Full Text] [Related]
26. Structural simplification of bioactive natural products with multicomponent synthesis. 4. 4H-pyrano-[2,3-b]naphthoquinones with anticancer activity.
Magedov IV; Kireev AS; Jenkins AR; Evdokimov NM; Lima DT; Tongwa P; Altig J; Steelant WF; Van slambrouck S; Antipin MY; Kornienko A
Bioorg Med Chem Lett; 2012 Aug; 22(16):5195-8. PubMed ID: 22819765
[TBL] [Abstract][Full Text] [Related]
27. Copper-catalyzed three-component synthesis of aminonaphthoquinone-sulfonylamidine conjugates and in vitro evaluation of their antiproliferative activity.
Suja TD; Divya KV; Naik LV; Ravi Kumar A; Kamal A
Bioorg Med Chem Lett; 2016 Apr; 26(8):2072-6. PubMed ID: 26948541
[TBL] [Abstract][Full Text] [Related]
28. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
29. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.
Bhasin D; Etter JP; Chettiar SN; Mok M; Li PK
Bioorg Med Chem Lett; 2013 Dec; 23(24):6864-7. PubMed ID: 24176397
[TBL] [Abstract][Full Text] [Related]
30. Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy.
Chrastina A; Welsh J; Rondeau G; Abedinpour P; Borgström P; Baron VT
ChemMedChem; 2020 Jul; 15(14):1338-1347. PubMed ID: 32410390
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of Succinimide-Containing Chromones, Naphthoquinones, and Xanthones under Rh(III) Catalysis: Evaluation of Anticancer Activity.
Han SH; Kim S; De U; Mishra NK; Park J; Sharma S; Kwak JH; Han S; Kim HS; Kim IS
J Org Chem; 2016 Dec; 81(24):12416-12425. PubMed ID: 27978756
[TBL] [Abstract][Full Text] [Related]
33. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
[TBL] [Abstract][Full Text] [Related]
34. 1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma.
Liu YM; HuangFu WC; Huang HL; Wu WC; Chen YL; Yen Y; Huang HL; Nien CY; Lai MJ; Pan SL; Liou JP
Eur J Med Chem; 2017 Nov; 140():84-91. PubMed ID: 28923389
[TBL] [Abstract][Full Text] [Related]
35. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
Scotti A; Trapella C; Ferretti V; Gallerani E; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2016; 31(3):456-63. PubMed ID: 25942361
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative and proapoptotic activities of aza-annulated naphthoquinone analogs.
Suárez-Rozas C; Simpson S; Fuentes-Retamal S; Catalán M; Ferreira J; Theoduloz C; Mella J; Cabezas D; Cassels BK; Yáñez C; Castro-Castillo V
Toxicol In Vitro; 2019 Feb; 54():375-390. PubMed ID: 30389605
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform.
Ning X; Qi H; Li R; Jin Y; McNutt MA; Yin Y
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):126-129. PubMed ID: 29185365
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Anticancer Evaluation of 1,4-Naphthoquinone Derivatives Containing a Phenylaminosulfanyl Moiety.
Ravichandiran P; Subramaniyan SA; Kim SY; Kim JS; Park BH; Shim KS; Yoo DJ
ChemMedChem; 2019 Mar; 14(5):532-544. PubMed ID: 30600915
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II.
Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
